Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
I-Hung Shao, Chia-Chen Wu, Hueih-Shing Hsu, Shyh-Chyi Chang, Hsu-Hsiang Wang, Heng-Chang Chuang & Yuan-Yun Tam. (2016) The effect of nocturia on sleep quality and daytime function in patients with lower urinary tract symptoms: a cross-sectional study. Clinical Interventions in Aging 11, pages 879-885.
Read now
Read now
Rebecca G. Rogers, Gloria Bachmann, Harriette Scarpero, Zhanna Jumadilova, Franklin Sun, Jon D. Morrow, Zhonghong Guan & Tamara Bavendam. (2009) Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Current Medical Research and Opinion 25:9, pages 2159-2165.
Read now
Read now
Articles from other publishers (38)
Cristina Frange. 2023. Clinical Cases in Sleep Physical Therapy. Clinical Cases in Sleep Physical Therapy
159
166
.
Fabian Aschwanden & Hansjörg Danuser. (2022) Nykturie – Epidemiologie, Pathophysiologie und TherapieNocturia – Epidemiology, pathophysiology and treatment. Journal für Urologie und Urogynäkologie/Österreich 29:1, pages 18-25.
Crossref
Crossref
Fabian Aschwanden & Hansjörg Danuser. (2021) Nykturie – Epidemiologie, Pathophysiologie und TherapieNycturie – épidémiologie, pathophysiologie et thérapie. Urologie in der Praxis 23:4, pages 136-143.
Crossref
Crossref
Adrian S. Wagg, Sender Herschorn, Martin Carlsson, Mireille Fernet & Matthias Oelke. (2021) What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine. Neurourology and Urodynamics 40:6, pages 1559-1568.
Crossref
Crossref
Megan Doyle-McClam, Muhammad H. Shahid, Jigme M. Sethi & Patrick Koo. (2018) Nocturia in Women With Obstructive Sleep Apnea. American Journal of Lifestyle Medicine 15:3, pages 260-268.
Crossref
Crossref
Kübra YILDIRIM, Ege AĞIRMAN & Seçil GUNHER ARICA. (2021) Urinary incontinence frequency and affecting factors in women 18 years and over18 yaş ve üzeri kadınlarda üriner inkontinans sıklığı ve etkileyen faktörler. Family Practice and Palliative Care 6:1, pages 22-28.
Crossref
Crossref
Ian Milsom, Adrian Wagg, Matthias Oelke & Christopher Chapple. (2020) Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions. International Journal of Clinical Practice 75:4.
Crossref
Crossref
Jay JhaveriMarjolaine Gauthier-LoisellePatrick Gagnon-SanschagrinEric Q. Wu. (2019) The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey Analysis. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1398-1408.
Crossref
Crossref
Matthias Oelke, Stefan De Wachter, Marcus J. Drake, Antonella Giannantoni, Mike Kirby, Susan Orme, Jonathan Rees, Philip van Kerrebroeck & Karel Everaert. (2017) A practical approach to the management of nocturia. International Journal of Clinical Practice 71:11, pages e13027.
Crossref
Crossref
Judy Yuen-man Siu. (2015) Communicating with mismatch and tension: treatment provision experiences of primary care doctors treating patients with overactive bladder in Hong Kong. BMC Family Practice 16:1.
Crossref
Crossref
Tony Nimeh, Pedro Alvarez, Naem Mufarreh & Lori B. Lerner. (2015) Nocturia: Current Evaluation and Treatment for Urology. Current Urology Reports 16:9.
Crossref
Crossref
Adriana de Carvalho Lacombe, Virginia Martello Riccobene & Leandro Alberto Calazans Nogueira. (2015) Effectiveness of a program of therapeutic exercises on the quality of life and lumbar disability in women with Stress Urinary Incontinence. Journal of Bodywork and Movement Therapies 19:1, pages 82-88.
Crossref
Crossref
Judy Yuen-man Siu. (2014) "Seeing a doctor is just like having a date": a qualitative study on doctor shopping among overactive bladder patients in Hong Kong. BMC Family Practice 15:1.
Crossref
Crossref
Judy Yuen-man Siu. (2014) The Illness Experiences of Women with Overactive Bladder in Hong Kong. Qualitative Health Research 24:6, pages 801-810.
Crossref
Crossref
Vik Khullar, Monserrat Espuna-Pons, Daniela Marschall-Kehrel, Aino Fianu-Jonasson, Con J. Kelleher, Linda Brubaker, James Beach, Elisabeth Piault & Jeffrey Trocio. (2014) Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms. Neurourology and Urodynamics 33:1, pages 90-94.
Crossref
Crossref
K. S. Coyne, A. Wein, S. Nicholson, M. Kvasz, C.-I. Chen & I. Milsom. (2013) Comorbidities and personal burden of urgency urinary incontinence: a systematic review. International Journal of Clinical Practice 67:10, pages 1015-1033.
Crossref
Crossref
Vik Khullar, Daniela Marschall-Kehrel, Montserrat Espuna-Pons, Con J. Kelleher, Shannon E. Tully, Elisabeth C. Piault, Linda Brubaker, Aino Fianu-Jonasson, David Weinstein, Agneta Bergqvist & Marion Kvasz. (2013) European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder. International Urogynecology Journal 24:9, pages 1529-1536.
Crossref
Crossref
Nadir I Osman & Christopher R Chapple. (2013) Focus on nocturia in the elderly. Aging Health 9:4, pages 389-402.
Crossref
Crossref
N. I. Osman, C. R. Chapple & A. J. Wein. (2012) Nocturia: current concepts and future perspectives. Acta Physiologica 207:1, pages 53-65.
Crossref
Crossref
J.L.H. Ruud Bosch & Jeffrey P. Weiss. (2013) The Prevalence and Causes of Nocturia. Journal of Urology 189:1S.
Crossref
Crossref
M. H. Palmer, A. Athanasopoulos, K.-S. Lee, M. Takeda & J.-J. Wyndaele. (2012) Sociocultural and environmental influences on bladder health. International Journal of Clinical Practice 66:12, pages 1132-1138.
Crossref
Crossref
Alan J. Wein & Christopher ChappleAlan J. Wein & Christopher Chapple. 2012. Overactive Bladder in Clinical Practice. Overactive Bladder in Clinical Practice
75
82
.
Alan J. Wein & Christopher ChappleAlan J. Wein & Christopher Chapple. 2012. Overactive Bladder in Clinical Practice. Overactive Bladder in Clinical Practice
41
57
.
Linda Brubaker, Vik Khullar, Elisabeth Piault, Christopher J. Evans, Tamara Bavendam, James Beach, Yating Yeh, Zoe S. Kopp, Con J. Kelleher & Jeffrey Trocio. (2011) Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire. International Urogynecology Journal 22:8, pages 937-946.
Crossref
Crossref
Jeffrey P. Weiss, Jerry G. Blaivas, Donald L. Bliwise, Roger R. Dmochowski, Catherine E. DuBeau, Franklin C. Lowe, Steven P. Petrou, Philip E.V. Van Kerrebroeck, Raymond C. Rosen & Alan J. Wein. (2011) The evaluation and treatment of nocturia: a consensus statement. BJU International 108:1, pages 6-21.
Crossref
Crossref
Daniela Marschall-Kehrel & Julian Spinks. (2011) The Patient-Centric Approach: The Importance of Setting Realistic Treatment Goals. European Urology Supplements 10:1, pages 23-27.
Crossref
Crossref
J.L.H. Ruud Bosch & Jeffrey P. Weiss. (2010) The Prevalence and Causes of Nocturia. Journal of Urology 184:2, pages 440-446.
Crossref
Crossref
Victor W. Nitti, Eric S. Rovner & Tamara Bavendam. (2010) Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU International 105:9, pages 1268-1275.
Crossref
Crossref
D. R. Staskin & L. Cardozo. (2009) Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release. International Journal of Clinical Practice 63:6, pages 973-976.
Crossref
Crossref
Rebecca Rogers, Gloria Bachmann, Zhanna Jumadilova, Franklin Sun, Jon D. Morrow, Zhonghong Guan & Tamara Bavendam. (2008) Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. International Urogynecology Journal 19:11, pages 1551-1557.
Crossref
Crossref
Eric S. Rovner, Raymond Rackley, Victor W. Nitti, Joseph T. Wang & Zhonghong Guan. (2008) Tolterodine Extended Release Is Efficacious in Continent and Incontinent Subjects with Overactive Bladder. Urology 72:3, pages 488-493.
Crossref
Crossref
Ulka B. Campbell, Paul Stang & Rich Barron. (2008) Survey Assessment of Continuation of and Satisfaction with Pharmacological Treatment for Urinary Incontinence. Value in Health 11:4, pages 726-732.
Crossref
Crossref
K. S. Coyne, V. Elinoff, D. A. Gordon, D. Y. Deng, M. Brodsky, D. B. Glasser, Z. Jumadilova & M. Carlsson. (2008) Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. International Journal of Clinical Practice 62:6, pages 925-931.
Crossref
Crossref
Karin S. Coyne, Louis S. Matza, Zoe S. Kopp, Christine Thompson, David Henry, Debra E. Irwin, Walter Artibani, Sender Herschorn & Ian Milsom. (2008) Examining lower urinary tract symptom constellations using cluster analysis. BJU International 101:10, pages 1267-1273.
Crossref
Crossref
Osamu Yamaguchi, Eiji Marui, Hidehiro Kakizaki, Naoki Itoh, Takashi Yokota, Hiroshi Okada, Osamu Ishizuka, Seiichiro Ozono, Momokazu Gotoh, Takahide Sugiyama, Narihito Seki & Masaki Yoshida. (2007) Randomized, double‐blind, placebo‐ and propiverine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU International 100:3, pages 579-587.
Crossref
Crossref
Alan D Garely, Vincent Lucente, Jonathan Vapnek & Neila Smith. (2016) Solifenacin for Overactive Bladder with Incontinence: Symptom Bother and Health-Related Quality of Life Outcomes. Annals of Pharmacotherapy 41:3, pages 391-399.
Crossref
Crossref
Shachi Tyagi, Catherine A. Thomas, Yukio Hayashi & Michael B. Chancellor. (2006) The Overactive Bladder: Epidemiology and Morbidity. Urologic Clinics of North America 33:4, pages 433-438.
Crossref
Crossref
Matt T. Rosenberg. (2006) Overactive bladder made ridiculously simple?. International Journal of Clinical Practice 60:6, pages 631-633.
Crossref
Crossref